Faz 找得到这篇新闻.
但是要付费才能观看, 可免费观看部分德文翻译成英文如下
BioNTech founder Ugur Sahin announced on Monday the successful end of a
geopolitical tightrope act: After months of standstill in negotiations with
Taipei, Taiwan is now to receive ten million doses of the BioNTech vaccine
against the corona virus. Numerous political cliffs were avoided because the
Taiwanese government was replaced by two leading Taiwanese corporations and a
foundation as buyers. The iPhone manufacturer Foxconn and the semiconductor
manufacturer TSMC want to donate the $ 350 million vaccine to the Taiwanese
health authorities.
BioNTech 创始人 Ugur Sahin 周一宣布，地缘政治角力的成功结束：在与台北的谈判停
滞数月后，台湾现在将收到 1000 万剂 BioNTech 冠状病毒疫苗。由于台湾政府被两家领
先的台湾公司和一个基金会取代，因此避免了许多政治悬崖。 iPhone制造商富士康和半
导体制造商台积电希望向台湾卫生当局捐赠3.5亿美元的疫苗。
What the explosive political power of this agreement is can be read from the
headline of the Mainz press release: The vaccine will be delivered to "the
Taiwan region", it says. Taiwan is only a region from the perspective of the
Chinese government, which regularly forces companies to adopt this
representation. In this case it has to do with the fact that it was not
BioNTech who negotiated the contract with the Taiwanese, but the Chinese
pharmaceutical company Fosun. Last year, BioNTech acquired the license to
market the Mainz-based corona vaccines exclusively on the Chinese mainland,
in Hong Kong, Macau - and also “in the Taiwan region”, as the Mainz press
release says.
这份协议的政治角力是什么，从Mainz新闻稿的标题可以看出：疫苗将交付给“台湾地区”
。从中国政府的角度来看，台湾只是一个地区，它经常迫使公司采用这种表示方式。
在这种情况下，与台湾谈判合同的不是BioNTech，而是中国制药公司复星。
正如Mainz新闻稿所说，去年，复星获得了在中国大陆、香港、澳门以及“台湾地区”
的独家销售许可。